Content
75%Weight 40%Scale 1-5Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
A well-structured specialist overview: dense tables, decision trees, explicit workflow checkpoints, executable script commands, and clearly signaled one-level references, with time-sensitive QMSR/QSR transitions responsibly framed as historical. Main gaps are inlined reference-depth content (diluting both conciseness and the overview role), missing error-recovery loops after checkpoints, and one orphaned reference file.
Suggestions
Move the detailed in-body workflows (design-controls steps, 7-step CAPA list, legacy QSR→ISO 13485 mapping table) into their respective reference files and keep only decision-level summaries plus links, tightening token cost and strengthening the overview role.
Link references/fda_capa_requirements.md from the CAPA section (it is currently listed only in Resources) so every reference file is discoverable from its topic section.
Add brief recovery guidance after each 510(k) workflow checkpoint (e.g., 'If SE argument infeasible → reassess predicate or pivot to De Novo; see pathway selection') to close the feedback loop, and include a worked example such as a sample substantial-equivalence comparison table.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | The body is dense and table-driven with no explanation of basic concepts Claude already knows, and time-sensitive details (QMSR transition date, FY2024 fees) are explicitly framed as historical with caveats to verify current figures. However, it inlines some content that belongs in the reference files — the legacy QSR→ISO 13485 mapping table and the full 7-step CAPA list duplicate what references/qsr_compliance_requirements.md and references/fda_capa_requirements.md are stated to contain — keeping it at anchor 4 ('minor instances that could be trimmed') rather than anchor 5. | 4 / 5 |
Actionability | Concrete, executable guidance is present throughout: copy-paste-ready script commands ('python scripts/fda_submission_tracker.py /path/to/project --type 510k'), specific CFR citations (21 CFR 807.87 required-sections table, §164.308/310/312 safeguards), a decision tree, and timelines/fees. It falls short of anchor 5 because there are no worked deliverable examples (e.g., a sample substantial-equivalence comparison or Q-Sub question set) and steps like 'Respond to AI requests' lack specifics. | 4 / 5 |
Workflow Clarity | The 4-phase 510(k) workflow has explicit checkpoints at each phase ('Checkpoint: SE argument feasible?', 'Checkpoint: Submission accepted?') and the design-controls workflow includes per-step verification questions, matching anchor 4's 'clear sequence with most checkpoints present'. It is not anchor 5 because checkpoints are questions without feedback loops — no 'if the checkpoint fails, do X' recovery guidance, and the RTA-issues table is not wired into the workflow as a recovery path. | 4 / 5 |
Progressive Disclosure | Each section ends with a clearly signaled one-level-deep reference link ('See [fda_submission_guide.md](references/fda_submission_guide.md)...') plus a Resources section listing scripts and references with purposes — good structure matching anchor 4. It misses anchor 5 because references/fda_capa_requirements.md is listed in Resources but never linked from the CAPA section (whose content is inlined instead), and reference-level depth (the full legacy→ISO mapping table) is duplicated in the body. Note: no bundle files were present in the evaluation directory to verify the referenced paths exist. | 4 / 5 |
Total | 16 / 20 Passed |